Perspective Therapeutics (CATX)
NYSE MKT:CATX
Holding CATX?
Track your performance easily

Perspective Therapeutics (CATX) Income Statement

1,054 Followers

Perspective Therapeutics Income Statement

Last quarter (Q2 2024), Perspective Therapeutics's total revenue was $526.00K, a decrease of -69.37% from the same quarter last year. In Q2, Perspective Therapeutics's net income was $-11.70M. See Perspective Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ 5.92M$ 1.43M$ 10.79M$ 2.71M$ 9.68M$ 7.31M
Cost of Revenue
$ 1.70M$ 298.00K$ 6.18M$ 4.93M$ 4.56M$ 4.27M
Gross Profit
$ 1.66M$ 1.43M$ 4.62M$ -4.93M$ 5.12M$ 3.05M
Operating Expense
$ 18.30M$ 42.38M$ 6.42M$ 8.56M$ 8.60M$ 8.32M
Operating Income
$ -15.57M$ -40.94M$ -6.42M$ -13.49M$ -3.48M$ -5.28M
Net Non Operating Interest Income Expense
$ 4.10M$ 850.00K$ 119.00K$ 59.00K$ 30.00K$ 108.00K
Other Income Expense
$ -3.23M$ -1.42M$ -2.13M$ -10.04M-$ 26.00K
Pretax Income
$ -36.09M$ -40.11M$ -6.30M$ -3.39M$ -3.45M$ -5.14M
Tax Provision
$ -10.50M$ -2.65M$ -32.00K---
Earnings From Equity Interest Net Of Tax
$ -4.00K$ -17.00K----
Net Income Common Stockholders
$ 498.00K$ -46.51M$ -7.27M$ -3.39M$ -3.46M$ -5.16M
Basic EPS
$ -0.24$ -3.40$ -0.05$ -0.03$ -0.05$ -0.08
Diluted EPS
$ -0.24$ -3.40$ -0.05$ -0.03$ -0.05$ -0.08
Basic Average Shares
$ 717.34M$ 26.76M$ 141.99M$ 103.84M$ 67.60M$ 67.04M
Diluted Average Shares
$ 717.34M$ 26.76M$ 141.99M$ 103.84M$ 67.60M$ 67.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 20.00M$ 42.67M$ 6.42M$ 13.49M$ 13.16M$ 12.59M
Net Income From Continuing And Discontinued Operation
$ -26.08M$ -46.51M$ -7.27M$ -3.39M$ -3.45M$ -5.14M
Normalized Income
$ -13.60M---$ -3.45M$ -5.17M
Interest Expense
------
EBIT
$ -35.80M$ -40.02M$ -7.39M$ -3.39M$ -3.48M$ -5.28M
EBITDA
$ -34.79M$ -39.04M$ -7.14M$ -3.20M$ -3.29M$ -5.09M
Currency in USD

Perspective Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis